Following this update, the company's stock price dropped more than 30 percent from market close Friday to $23.79 per share Monday morning.

Vaderis Therapeutics AG (Vaderis), a clinical stage biotechnology company focusing on treatments for rare diseases associated with vascular malformations, today announces that the US Food and Drug ...

Calidi Biotherapeutics continues to advance its clinical-stage, off-the-shelf, virotherapies. With RTNova, the company is planning multi-modal systemic antitumor virotherapies that can disrupt tumor ...

California is ready to say goodbye to a common labeling phrase at the grocery store that causes residents to waste major ...

It's often tricky to determine how much sugar is in food, even when you check the ingredients list. Here's what you need to ...

We are experiencing some temporary issues. The market data on this page is currently delayed. Please bear with us as we address this and restore your personalized lists.

IMNN-001 is an IL-12 DNA plasmid vector encased in a nanoparticle delivery system that ... followed by three additional cycles of adjuvant chemotherapy to treat any residual tumor. This open-label ...

Remolona is signaling a sustained monetary easing cycle even after Trump’s win in the US presidential elections could upend the Fed’s policy calculus. Expectations of a Fed rate cut next month have ...

(Bloomberg) -- Oil steadied after the biggest gain in more than five weeks as the dollar weakened and a risk-on tone swept across wider markets.

If confirmed as secretary of Health and Human Services, Kennedy would oversee the US Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) and the head of the Centers ...

(Bloomberg) -- A group representing Australia’s A$3.9 trillion ($2.5 trillion) pension industry has recommended its members vote against the remuneration plan of scandal-hit Mineral Resources Ltd. at ...

LOUISVILLE, Ky. (AP) — The family of a worker killed last week in an explosion at a Louisville manufacturing plant said ...